Stevanato Group S.p.A (STVN) Non-Current Deffered Revenue (2025)
Stevanato Group S.p.A (STVN) reported Non-Current Deffered Revenue of $13.8 million for Q4 2025.
Stevanato Group S.p.A (STVN) has 1 years of Non-Current Deffered Revenue data on file, last reported at $13.8 million in Q4 2025.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $13.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.8 million (changed N/A YoY) and the FY2025 annual result came in at $13.8 million, changed N/A from the prior year.
- Non-Current Deffered Revenue steadied at $13.8 million in Q4 2025 per STVN's latest filing.
- Across five years, Non-Current Deffered Revenue topped out at $13.8 million in Q4 2025 and bottomed at $13.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 163.15 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 11.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 206.40 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.78 Mn |